Evidence map›Paper›PMID 22272276›Full record

ArticlePloS one2012

Biapenem inactivation by B2 metallo β-lactamases: energy landscape of the post-hydrolysis reactions.

Domenico L Gatti

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Domenico L GattiDepartment of Biochemistry and Molecular Biology, Wayne State University School of Medicine, Detroit, Michigan, United States of America. dgatti@med.wayne.edu
Michigan United · US

Funding

Structure, mechanism and evolution of KDO8P synthaseR01GM069840 · NIGMS · WAYNE STATE UNIVERSITY · PI GATTI, DOMENICO L · 2004 to 2007
$1.1M
NIGMS NIH HHS GM69840NIGMS NIH HHS R01 GM069840
6 · The paper itself

Abstract

backgroundThe first line of defense by bacteria against β-lactam antibiotics is the expression of β-lactamases, which cleave the amide bond of the β-lactam ring. In the reaction of biapenem inactivation by B2 metallo β-lactamases (MβLs), after the β-lactam ring is opened, the carboxyl group generated by the hydrolytic process and the hydroxyethyl group (common to all carbapenems) rotate around the C5-C6 bond, assuming a new position that allows a proton transfer from the hydroxyethyl group to C2, and a nucleophilic attack on C3 by the oxygen atom of the same side-chain. This process leads to the formation of a bicyclic compound, as originally observed in the X-ray structure of the metallo β-lactamase CphA in complex with product. METHODOLOGY/PRINCIPAL

findingsQM/MM and metadynamics simulations of the post-hydrolysis steps in solution and in the enzyme reveal that while the rotation of the hydroxyethyl group can occur in solution or in the enzyme active site, formation of the bicyclic compound occurs primarily in solution, after which the final product binds back to the enzyme. The calculations also suggest that the rotation and cyclization steps can occur at a rate comparable to that observed experimentally for the enzymatic inactivation of biapenem only if the hydrolysis reaction leaves the N4 nitrogen of the β-lactam ring unprotonated. CONCLUSIONS/SIGNIFICANCE: The calculations support the existence of a common mechanism (in which ionized N4 is the leaving group) for carbapenems hydrolysis in all MβLs, and suggest a possible revision of mechanisms for B2 MβLs in which the cleavage of the β-lactam ring is associated with or immediately followed by protonation of N4. The study also indicates that the bicyclic derivative of biapenem has significant affinity for B2 MβLs, and that it may be possible to obtain clinically effective inhibitors of these enzymes by modification of this lead compound.

Indexed as

ThermodynamicsAeromonas hydrophilaAlgorithmsAnti-Infective AgentsBacterial Proteinsbeta-LactamasesBridged Bicyclo Compounds, HeterocyclicCatalytic DomainCrystallography, X-RayHydrolysisKineticsModels, ChemicalModels, MolecularMolecular Dynamics SimulationProtein BindingProtein ConformationAnti-Infective AgentsBacterial Proteinsbeta-LactamasesbiapenemBridged Bicyclo Compounds, HeterocyclicThienamycins

Identifiers

PMID22272276
PMCPMC3260057
OpenAlexW2071959985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.